Initial Highly Effective Therapy for MS
Neurol 95:1114-1116, Wallin, M.T., 2020
Acute Viral Encephalitis
NEJM 379:357-366, Tyler,K.L., 2018
Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
Complications from "Stem Cell Tourism" in Neurology
Ann Neurol 88:661-668, Julian, K.,et al, 2020
Comparative Analysis of Therapeutic Options Used for Myasthenia Gravis
Ann Neurol 68:797-805, Mandawat,A.,et al, 2010